Literature DB >> 10221746

A review of endocrine changes in anorexia nervosa.

R K Støving1, J Hangaard, M Hansen-Nord, C Hagen.   

Abstract

Anorexia nervosa is a syndrome of unknown etiology. It is associated with multiple endocrine abnormalities. Hypothalamic monoamines (especially serotonin), neuropeptides (especially neuropeptide Y and cholecystokinin) and leptin are involved in the regulation of human appetite, and in several ways they are changed in anorexia nervosa. However, it remains to be clarified whether the altered appetite regulation is secondary or etiologic. Increased secretion of corticotropin-releasing hormone and proopiomelanocortin seems to be secondary to starvation, however, there is evidence that it may maintain and intensify anorexia, excessive physical activity and amenorrhea. Hypothalamic amenorrhea, which is a diagnostic criterion in anorexia nervosa, is not solely related to the low body weight and exercise. Growth hormone resistance with low production of insulin-like growth factor I and high growth hormone secretion reflect the nutritional deprivation. The nutritional therapy of patients with anorexia nervosa might be improved by administering an anabolic agent such as growth hormone or insulin-like growth factor I. So far none of the endocrine abnormalities have proved to be primary, however, there is increasing evidence that some of these might participate in a vicious circle.

Entities:  

Mesh:

Year:  1999        PMID: 10221746     DOI: 10.1016/s0022-3956(98)00049-1

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  22 in total

1.  Research methodology: endocrinologic measurements in exercise science and sports medicine.

Authors:  Anthony C Hackney; Atko Viru
Journal:  J Athl Train       Date:  2008 Oct-Dec       Impact factor: 2.860

2.  Autoantibodies against alpha -MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients.

Authors:  Sergueï O Fetissov; Jarmila Hallman; Lars Oreland; Britt Af Klinteberg; Eva Grenbäck; Anna-Lena Hulting; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 3.  The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects.

Authors:  G Abbate Daga; L Gianotti; V Mondelli; R Quartesan; S Fassino
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

4.  Long term mortality after severe starvation during the siege of Leningrad: prospective cohort study.

Authors:  Pär Sparén; Denny Vågerö; Dmitri B Shestov; Svetlana Plavinskaja; Nina Parfenova; Valeri Hoptiar; Dominique Paturot; Maria Rosaria Galanti
Journal:  BMJ       Date:  2003-12-05

Review 5.  Neurobiology of anorexia and bulimia nervosa.

Authors:  Walter Kaye
Journal:  Physiol Behav       Date:  2007-11-29

6.  The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa.

Authors:  F Lanfranco; L Gianotti; A Picu; S Fassino; G Abbate Daga; V Mondelli; R Giordano; S Grottoli; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 7.  The endocrinopathies of anorexia nervosa.

Authors:  Lisa S Usdan; Lalita Khaodhiar; Caroline M Apovian
Journal:  Endocr Pract       Date:  2008-11       Impact factor: 3.443

8.  Leptin does not mediate short-term fasting-induced changes in growth hormone pulsatility but increases IGF-I in leptin deficiency states.

Authors:  Jean L Chan; Catherine J Williams; Patricia Raciti; Jennifer Blakeman; Theodore Kelesidis; Iosif Kelesidis; Michael L Johnson; Michael O Thorner; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

9.  Disturbances in gonadal axis in women with anorexia nervosa.

Authors:  A Tomova; K Makker; G Kirilov; A Agarwal; P Kumanov
Journal:  Eat Weight Disord       Date:  2007-12       Impact factor: 4.652

Review 10.  GH/IGF-I axis in anorexia nervosa.

Authors:  L Gianotti; F Lanfranco; J Ramunni; S Destefanis; E Ghigo; E Arvat
Journal:  Eat Weight Disord       Date:  2002-06       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.